Biotechnology manufacturer
H.R. 6, the 21st Century Cures Act
Policy issues relation to Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act, specifically Section 902 relating to the Breakthrough Therapy Designation for pharmaceuticals
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAKER & HOSTETLER LLP
1050 Connecticut Ave NW Suite 1100, Washington, DC, 20036, US
CHRIS JONES ADAM HIGGINS TYLER THOMPSON